Utah Medical Products Toekomstige groei

Future criteriumcontroles 0/6

Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Utah Medical Products te voorspellen.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Medical Equipment winstgroei	17.1%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Recent updates

Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

May 01

Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Mar 26

Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Mar 02

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 11

Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Jan 27

Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Jan 13

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Dec 29

Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Dec 15

Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Nov 30

Utah Medical Products declares $0.285 dividend

Nov 03

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Utah Medical Products onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

NasdaqGS:UTMD - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
9/30/2024	44	15	17	17	N/A
6/30/2024	47	16	18	18	N/A
3/31/2024	49	16	20	21	N/A
12/31/2023	50	17	22	22	N/A
9/30/2023	51	17	22	23	N/A
6/30/2023	52	17	22	23	N/A
3/31/2023	52	17	22	23	N/A
12/31/2022	52	16	20	21	N/A
9/30/2022	52	16	19	20	N/A
6/30/2022	51	16	20	21	N/A
3/31/2022	50	15	20	21	N/A
12/31/2021	49	15	21	21	N/A
9/30/2021	48	14	22	22	N/A
6/30/2021	46	13	21	21	N/A
3/31/2021	42	11	20	20	N/A
12/31/2020	42	11	19	20	N/A
9/30/2020	42	12	19	20	N/A
6/30/2020	44	13	20	21	N/A
3/31/2020	47	15	18	19	N/A
12/31/2019	47	15	-4	17	N/A
9/30/2019	45	14	-6	16	N/A
6/30/2019	43	17	-7	14	N/A
3/31/2019	42	18	-5	16	N/A
12/31/2018	42	19	16	17	N/A
9/30/2018	42	13	15	17	N/A
6/30/2018	42	10	N/A	17	N/A
3/31/2018	42	9	N/A	16	N/A
12/31/2017	41	9	N/A	17	N/A
9/30/2017	40	14	N/A	16	N/A
6/30/2017	40	13	N/A	15	N/A
3/31/2017	39	12	N/A	15	N/A
12/31/2016	39	12	N/A	15	N/A
9/30/2016	40	13	N/A	15	N/A
6/30/2016	40	13	N/A	16	N/A
3/31/2016	40	12	N/A	16	N/A
12/31/2015	40	12	N/A	14	N/A
9/30/2015	41	12	N/A	14	N/A
6/30/2015	41	11	N/A	15	N/A
3/31/2015	41	11	N/A	16	N/A
12/31/2014	41	11	N/A	15	N/A
9/30/2014	41	12	N/A	14	N/A
6/30/2014	40	12	N/A	13	N/A
3/31/2014	40	11	N/A	12	N/A
12/31/2013	40	11	N/A	12	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van UTMD boven de spaarquote ( 2.6% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van UTMD naar verwachting sneller zal groeien dan de markt US

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van UTMD naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van UTMD naar verwachting sneller zal groeien dan de markt US.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van UTMD naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van UTMD naar verwachting over 3 jaar hoog zal zijn

Utah Medical Products Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Utah Medical Products, Inc. Provides Earnings Guidance for the Second Quarter of 2021

Recent updates

Utah Medical Products, Inc. Appoints Carrie Leigh to Its Board of Directors

Third quarter 2024 earnings released: EPS: US$1.03 (vs US$1.08 in 3Q 2023)

Upcoming dividend of US$0.30 per share

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Second quarter dividend of US$0.30 announced

Second quarter 2024 earnings released: EPS: US$0.98 (vs US$1.16 in 2Q 2023)

Upcoming dividend of US$0.30 per share

First quarter dividend of US$0.30 announced

First quarter 2024 earnings released: EPS: US$1.09 (vs US$1.16 in 1Q 2023)

Utah Medical Products, Inc., Annual General Meeting, May 03, 2024

Full year 2023 earnings released: EPS: US$4.58 (vs US$4.53 in FY 2022)

Utah Medical Products: An Attractive, But Speculative, Prospect

Upcoming dividend of US$0.30 per share

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Fourth quarter dividend of US$0.30 announced

Full year 2023 earnings released: EPS: US$4.57 (vs US$4.53 in FY 2022)

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 1.5% yield

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Third quarter 2023 earnings released: EPS: US$1.08 (vs US$1.18 in 3Q 2022)

Upcoming dividend of US$0.29 per share at 1.3% yield

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on October 3, 2023

Second quarter 2023 earnings released: EPS: US$1.15 (vs US$1.13 in 2Q 2022)

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.29 per share at 1.2% yield

Independent Director recently sold US$65k worth of stock

Utah Medical Products, Inc. Announces Quarterly Dividend Payable on July 6, 2023

Full year 2022 earnings released

Now 22% undervalued after recent price drop

Upcoming dividend of US$0.29 per share at 1.3% yield

Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on April 4, 2023

Now 21% undervalued

Full year 2022 earnings released: EPS: US$4.52 (vs US$4.06 in FY 2021)

A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Upcoming dividend of US$0.29 per share

Investor sentiment improved over the past week

Insufficient new directors

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on January 4, 2023

Third quarter 2022 earnings released: EPS: US$1.18 (vs US$1.15 in 3Q 2021)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Utah Medical Products declares $0.29 dividend

Second quarter 2022 earnings released: EPS: US$1.12 (vs US$0.94 in 2Q 2021)

Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Independent Director recently sold US$170k worth of stock

Independent Director notifies of intention to sell stock

First quarter 2022 earnings released

Insufficient new directors

Utah Medical Products, Inc., Annual General Meeting, May 06, 2022

Full year 2021 earnings released: EPS: US$4.06 (vs US$2.95 in FY 2020)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Independent Director notifies of intention to sell stock

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Inaugural dividend of US$2.00 per share

Independent Director notifies of intention to sell stock

Independent Director recently sold US$222k worth of stock

Third quarter 2021 earnings released: EPS US$1.15 (vs US$0.81 in 3Q 2020)

Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Upcoming dividend of US$0.28 per share

Independent Director recently sold US$176k worth of stock

Independent Director notifies of intention to sell stock

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

Second quarter 2021 earnings released: EPS US$0.94 (vs US$0.36 in 2Q 2020)

Upcoming dividend of US$0.28 per share

First quarter 2021 earnings released: EPS US$0.83 (vs US$0.85 in 1Q 2020)